Literature DB >> 24855505

Human nerual stem cells for brain repair.

Seung U Kim1, Hong J Lee2, In H Park2, Kon Chu3, Soon T Lee3, Manho Kim3, Jae K Roh3, Seung K Kim4, Kyu C Wang4.   

Abstract

Cell replacement therapy and gene transfer to the diseased or injured brain have provided the basis for the development of potentially powerful new therapeutic strategies for a broad spectrum of human neurological diseases including Parkinson disease, Huntington disease, amyotrophic lateral sclerosis (ALS), Alzheimer disease, multiple sclerosis (MS), stroke, spinal cord injury and brain cancer. In recent years, neurons and glial cells have successfully been generated from neural stem cells, and extensive efforts by investigators to develop neural stem cell-based transplantation therapies have been carried out. We review here notable experimental and pre-clinical studies we have previously conducted involving human neural stem cell-based cell- and gene-therapies for Parkinson disease, Huntington disease, ALS, stroke and brain cancer.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Brain cancer; Cell therapy; Gene transfer; Human neural stem cell; Huntington disease; Neurodegenrative diseases; Parkinson disease; Stem cell; Stroke; Transplantation

Year:  2008        PMID: 24855505      PMCID: PMC4021772          DOI: 10.15283/ijsc.2008.1.1.27

Source DB:  PubMed          Journal:  Int J Stem Cells        ISSN: 2005-3606            Impact factor:   2.500


  73 in total

1.  Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts.

Authors:  C Bencsics; S R Wachtel; S Milstien; K Hatakeyama; J B Becker; U J Kang
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 2.  Medulloblastoma: clinical and biologic aspects.

Authors:  R J Packer; P Cogen; G Vezina; L B Rorke
Journal:  Neuro Oncol       Date:  1999-07       Impact factor: 12.300

3.  Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain.

Authors:  M Bergeron; J M Gidday; A Y Yu; G L Semenza; D M Ferriero; F R Sharp
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

Review 4.  Excitotoxic injury of the neostriatum: a model for Huntington's disease.

Authors:  M DiFiglia
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.

Authors:  Alice B Brown; Wendy Yang; Nils O Schmidt; Rona Carroll; Kim K Leishear; Nikolai G Rainov; Peter M Black; Xandra O Breakefield; Karen S Aboody
Journal:  Hum Gene Ther       Date:  2003-12-10       Impact factor: 5.695

7.  Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.

Authors:  Jae K Ryu; Jean Kim; Sung J Cho; Kozo Hatori; Astushi Nagai; Hyun B Choi; Min C Lee; James G McLarnon; Seung U Kim
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

8.  Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling.

Authors:  Stephen E Kendall; Joseph Najbauer; Heather F Johnston; Marianne Z Metz; Shan Li; Marisa Bowers; Elizabeth Garcia; Seung U Kim; Michael E Barish; Karen S Aboody; Carlotta A Glackin
Journal:  Stem Cells       Date:  2008-03-13       Impact factor: 6.277

9.  Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.

Authors:  David Lin; Joseph Najbauer; Paul M Salvaterra; Adam N Mamelak; Michael E Barish; Elizabeth Garcia; Marianne Z Metz; Stephen E Kendall; Marisa Bowers; Babak Kateb; Seung U Kim; Margaret Johnson; Karen S Aboody
Journal:  Neuroimage       Date:  2007-05-13       Impact factor: 6.556

10.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

View more
  4 in total

1.  In Vitro Differentiation and Expansion of Intrathymic T Cell Progenitors from Human Umbilical Cord Blood-Derived CD34(+) Cells.

Authors:  Bo Sun; Sang-Bum Park; Ji-Won Jung; Kwang-Won Seo; Yong-Soon Lee; Kyung-Sun Kang
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 2.  Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease.

Authors:  Kyung-Bok Lee; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

3.  Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.

Authors:  Jana Portnow; Timothy W Synold; Behnam Badie; Revathiswari Tirughana; Simon F Lacey; Massimo D'Apuzzo; Marianne Z Metz; Joseph Najbauer; Victoria Bedell; Tien Vo; Margarita Gutova; Paul Frankel; Mike Chen; Karen S Aboody
Journal:  Clin Cancer Res       Date:  2016-12-15       Impact factor: 12.531

4.  Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients.

Authors:  Jana Portnow; Behnam Badie; M Suzette Blanchard; Julie Kilpatrick; Revathiswari Tirughana; Marianne Metz; Shu Mi; Vivi Tran; Julie Ressler; Massimo D'Apuzzo; Karen S Aboody; Timothy W Synold
Journal:  Cancer Gene Ther       Date:  2020-09-08       Impact factor: 5.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.